All Things mRNA: Strategies for Effective mRNA Vaccine and…
mRNA vaccines and therapeutics continue to reshape medicine, providing unique opportunities to prevent and treat a wide range of diseases.…
A novel RNA polymerase variant for reduced dsRNA byproducts…
As mRNA therapeutics expand into cancer vaccines, cell therapies and beyond, manufacturing high-quality mRNA with minimal byproducts is more critical…
Simplifying manufacturing of alphavirus self-amplifying RNA…
How CleanCap® co-transcriptional capping strategy can be advantageous TriLink’s CleanCap® AU analog is designed for the co-transcriptional capping of RNA…
Panel Discussion: Getting Started with mRNA-Based Therapeutics
Moderated by Kevin Davies, PhD, Executive Editor, The CRISPR Journal Dr. Kevin Davies: In this discussion, we will be talking…
Next-Generation mRNA Capping Technologies on Personalized Medicine and Cancer Immunotherapies
Segmentation of Next-Generation mRNA Capping Technologies Market (PharmaNewsWire.Com, April 11, 2025 ) InsightAce Analytic Pvt. Ltd. announces the release of…
Antibody Conjugate Oligonucleotide Market Future Outlook and Growth Prospects in Oncology and Genetic Disorders
Segmentation of Antibody Conjugate Oligonucleotide Market(PharmaNewsWire.Com, April 11, 2025 ) InsightAce Analytic Pvt. Ltd. announces the release of a market…